Mechanism of Action of Ocrelizumab
Introduction Ocrelizumab is a monoclonal antibody used in multiple sclerosis. It is marketed as Ocrevus for intravenous infusion. Ocrelizumab is also the active anti-CD20 antibody component in Ocrevus Zunovo, a subcutaneous formulation that contains ocrelizumab with hyaluronidase. Pharmacologically, ocrelizumab is a CD20-directed cytolytic monoclonal antibody. It is designed to target CD20-positive B lymphocytes, which are … Read more